Mammalian chromatin remodeling factor, SWI/SNF complex contains a single molecule of either Brm or BRG1 as the ATPase catalytic subunit. Here, we show that the SWI/SNF complex forms a larger complex with neuron-restrictive silencer factor (NRSF) and its corepressors, mSin3A and CoREST, in human nonsmall cell lung carcinoma cell lines. We also demonstrate that the strong transcriptional suppression of such neuron-specific genes as synaptophysin and SCG10 by NRSF in these non-neural cells requires the functional SWI/SNF complex; these neuronal genes were elevated in cell lines deficient in both Brm and BRG1, whereas retrovirus vectors expressing siRNAs targeting integral components of SWI/SNF complex (Brm/BRG1 or Ini1) induced expression of these neuronal genes in SWI/SNF-competent cell lines. In cell lines deficient in both Brm and BRG1, exogenous Brm or BRG1 suppressed expression of these neuronal genes in an ATP-dependent manner and induced efficient and specific deacetylation of histone H4 around the NRSF binding site present in the synaptophysin gene by a large complex containing the recruited functional SWI/SNF complex. Patients with Brm/BRG1-deficient lung carcinoma have been reported to carry poor prognosis; derepression of NRSF-regulated genes including these neuron-specific genes could contribute to enhance tumorigenicity and also would provide selective markers for Brm/BRG1-deficient tumors.
Introduction
The chromatin remodeling factor SWI/SNF complex has been shown to play pivotal roles in epigenetic regulation by directly changing the structure of nucleosomes in an ATP-dependent manner (Sudarsanam and Winston, 2000; Iba et al., 2003; Martens and Winston, 2003) . Each mammalian SWI/SNF complex consists of approximately 10 subunits, and each complex contains a single molecule of Brm or BRG1 as the catalytic ATPase subunit (Wang et al., 1996) . It has been reported that transcription factors including C/EBP, c-Myc and cFos/c-Jun can activate their target genes by cooperating with the SWI/SNF complex, which can remodel nucleosomes and increase accessibility of transcription factors to target loci (Cheng et al., 1999; Kowenz-Leutz and Leutz, 1999; Ito et al., 2001 ). In the case of the cFos/c-Jun heterodimer, we have reported that the heterodimer binds with high affinity to the BAF60a subunit and recruits the SWI/SNF complex to AP-1 DNA binding sites located in relatively inactive chromatin to transactivate transcription (Ito et al., 2001; Yamamichi-Nishina et al., 2003) . The SWI/SNF complex has also been reported to be involved in the development of cancer (Roberts and Orkin, 2004) . For example, a majority of malignant human rhabdoid tumors have biallelic loss of the Ini1 gene, which encodes one subunit of the SWI/SNF complex (Versteege et al., 1998) . Mutations in BRG1 have been detected in human tumor cell lines derived from prostate, breast, pancreas and lung carcinomas (Wong et al., 2000; Reisman et al., 2002) . Several groups, including ours, have reported that certain nonsmall cell lung carcinoma (NSCLC) cell lines (Wong et al., 2000; Yamamichi et al., 2005) and primary NSCLC (Reisman et al., 2003; Fukuoka et al., 2004) frequently lack expression of both Brm and BRG1.
We have been interested in the biological properties of Brm/BRG1-deficient NSCLC cell lines, because these cells are expected to be epigenetically unstable owing to the lack of functional SWI/SNF complexes. Since our preliminary experiments indicated that some neuronal genes are expressed in these cell lines, we first examined whether the lack of both Brm and BRG1 expression led to the disturbance of neuron-specific genes in NSCLC cell lines. In general, expression of neuron-specific genes is strictly suppressed at the level of transcription in nonneuronal cells; however, a small population of normal lung cells (pulmonary neuroendocrine cells, PNECs) and some lung carcinoma cells, such as small-cell lung carcinoma (SCLC), have been shown to express neuroendocrine (NE) marker genes (Linnoila, 1996; Van Lommel et al., 1999) , suggesting that deregulation of neuron-specific genes occasionally arises in lungderived cells despite their origin in endoderm. As for regulation of neuronal gene expression, there are two important transcription factors, a positive regulator, mammalian achaete-scute homologue-1 (Mash1, also called hAsh1 in humans) and a negative regulator, neuron-restrictive silencer factor (NRSF; also designated as repressor element 1 (RE1)-silencing transcription factor (REST)). Mash1 appears to be essential for NE differentiation in normal PNECs (Borges et al., 1997) . SCLC, which is often thought to originate from PNEC progenitors, has been also shown to express Mash1 protein (Borges et al., 1997) . On the other hand, terminally differentiated non-neural cells specifically express NRSF as a neuronal gene silencer (Chong et al., 1995; Schoenherr and Anderson, 1995) . This zinc-finger transcription factor is a member of the Gli-Kru¨ppel family and blocks transcription of several neuron-specific genes by binding to a conserved 23-bp sequence, neuron-restrictive silencer element (NRSE, also known as RE1; Chong et al., 1995; Schoenherr and Anderson, 1995) . It has been reported that loss of functional NRSF (200-kDa in size) or the appearance of its neural-type splice variant, 50-kDa hREST4, which probably functions as a dominant negative mutant, contributes to expression of neuron-specific genes in a subgroup of SCLC (Coulson et al., 2000; Gurrola-Diaz et al., 2003) .
Here, we show that in human NSCLC cell lines, deficiency of both Brm and BRG1 associates with the abilities of these cell lines to express such neuron-specific genes as synaptophysin and SCG10. We also show that these NSCLC cell lines do not express Mash1 but do possess functional NRSF, indicating that this aberrant expression of neuron-specific genes is caused by loss of SWI/SNF function, but not by known molecular mechanisms in SCLC. Lastly, we demonstrate that the SWI/SNF complex forms a unique larger complex that includes both NRSF and mSin3A to block expression of these neuronal genes through histone deacetylation rather than DNA methylation.
Results and discussion
NSCLC cell lines deficient in Brm and BRG1 express a subset of neuron-specific genes We have screened several human NSCLC cell lines for expression of the Brm and BRG1 proteins by Western blotting (Figure 1a and data not shown) and identified three cell lines, NCI-H23, NCI-H522 and A427, which do not express both Brm and BRG1. In NCI-H1299 and A549 cells, Brm but not BRG1 was expressed. These results are consistent with those of previous reports (Reisman et al., 2002 (Reisman et al., , 2003 Wong et al., 2000; Yamamichi et al., 2005) . In the present experiments, we also used NCI-H596, a NSCLC cell line that expresses both Brm and BRG1 proteins like HeLaS3 and IMR-32 ( Figure 1a ). SWI/SNF core components BAF155 and Ini1 were expressed in all the NSCLC cell lines examined here (Figure 1a) .
Expression of mRNAs for representative neuronspecific genes, such as synaptophysin, SCG10 and synapsin I, was examined by semiquantitative reverse transcription-polymerase chain reactions (RT-PCR) (Figure 1b) . The three Brm/BRG1-deficient cell lines expressed these three mRNAs at higher levels than other NSCLC cell lines examined. Synaptophysin and synapsin I were expressed at low levels in A549 and NCI-H1299 cells, respectively. NCI-H596 cells, which express both Brm and BRG1, did not express detectable levels of synaptophysin, synapsin I or SCG10 under these PCR Neuronal gene induction in Brm/BRG1-deficient cell lines H Watanabe et al conditions. Therefore, the absence of both ATPase subunits of the SWI/SNF complex is associated with expression of these three neuron-specific mRNAs in human NSCLC cell lines. Western blotting revealed that NCI-H522 and A427 cells, but not NCI-H596 and HeLaS3, express synaptophysin protein like the IMR-32 neuroblastoma cell line (Figure 1c) , indicating that the synaptophysin mRNA is certainly translated.
As a bHLH transcription factor, Mash1, is involved in neuronal determination and NE differentiation of several tissues, including a small population of lung epithelial cells and most SCLC cell lines (Borges et al., 1997) , we examined expression of Mash1 mRNA by RT-PCR. Mash1 mRNA was expressed only in the IMR-32 neuroblastoma cell line (Figure 2a ), indicating that induction of expression of neuron-specific genes is caused by mechanisms different from those previously reported for SCLC cells (Borges et al., 1997) .
To test whether loss of full-length NRSF expression or appearance of neural-type NRSF (hREST4), which is often expressed in SCLC cells (Coulson et al., 2000) , induces expression of neuron-specific genes, we performed semiquantitative RT-PCR using NRSF primers that discriminate between full-length and neural-type NRSF mRNAs (Figure 2a) . All of the NSCLC cell lines and HeLaS3 cells expressed full-length NRSF transcript, whereas IMR-32 cells synthesized large amounts of the neural-type mRNA that encodes hREST4, and a small amount of the full-length mRNA (Figure 2a ). Western blot analysis showed that there was an approximately 200-kDa signal that represented full-length NRSF protein, in HeLaS3, NCI-H596 and NCI-H522 cells (data not shown). Two important corepressors of NRSF, CoREST (Andres et al., 1999; Grimes et al., 2000; Ballas et al., 2001 ) and mSin3A (Huang et al., 1999; Naruse et al., 1999; Roopra et al., 2000) were detectable in all of the NSCLC cell lines examined here ( Figure 2b ). These results indicate that the derepression of neuron-specific genes in these Brm/BRG1-deficient NSCLC cell lines is not caused by loss of NRSF, CoREST or mSin3A.
Repression of neuronal gene expression is maintained through the SWI/SNF complex To examine whether the SWI/SNF complex is involved directly in repression of endogenous neuron-specific genes, we transfected Brm and BRG1 expression vectors that coexpress GFP protein into NCI-H522 cells (Figure 3a) . At 3 days after the transfection, GFPpositive cells were sorted and harvested for total RNA preparation, and levels of several mRNAs were determined by semiquantitative RT-PCR. When we screened for genes that are positively regulated by the SWI/SNF complex, we found that expression of IL-6 mRNA was induced specifically by expression of either Brm or BRG1 in NCI-H522 cells. But the transactivation was abolished when Brm or BRG1 was substituted with its mutant deficient in ATPase activity, Brm (ATPmut) (Muchardt and Yaniv, 1993) or BRG1 (KR) (Khavari et al., 1993) , respectively (Figure 3b and c). The human IL-6 promoter region contains binding sites for C/EBP and AP-1 (Vanden Berghe et al., 1999), which are known to bind the SWI/SNF complex (Kowenz-Leutz and Leutz, 1999; Ito et al., 2001; Yamamichi-Nishina et al., 2003) . Therefore, the complemented SWI/SNF complex would be recruited to the IL-6 promoter, indicating that the exogenously expressed Brm and BRG1 proteins are fully functional for transcriptional activation. In contrast, exogenous expression of Brm or BRG1 in NCI-H522 cells resulted in the specific downregulation of synaptophysin mRNA to a level similar to that in NCI-H596 cells (Figure 3b and c). Expression of SCG10 was also repressed by exogenous BRG1 modestly, but not by Brm (Figure 3b and c). No significant decrease of synaptophysin and SCG10 mRNA was observed by introducing the exogenous Brm (ATPmut) or BRG1 (KR) mutant. These results indicate that the SWI/SNF complex can suppress expression of some neuron-specific genes in NCI-H522 cells in an ATPase-dependent manner. It is also noteworthy that SWI/SNF complex functions as both a positive and a negative regulator in the same cell. Expression of synapsin I, however, was not affected after introduction of any constructs in NCI-H522 cells (Figure 3b and c), indicating that the SWI/SNF complex is dispensable for the suppression of the synapsin I gene in this cell line.
To clarify the suppressive function of the SWI/SNF complex in neuron-specific genes in non-neural cells, we introduced retrovirus vectors expressing short hairpin (sh) RNAs targeting the Brm, BRG1 and Ini1 genes (designated shBrm, shBRG1 and shIni1, respectively) into NCI-H596 and HeLaS3 cells. Stable transductants were harvested for the preparation of total protein for Western blot analysis. shBrm (two species; No. 1, 2), shBRG1 and shIni1 specifically inhibited expression of Brm, BRG1 and Ini1, respectively, when tested in HeLaS3 and NCI-H596 cells (Figure 4a and data not Figure 1a were analysed by Western blotting with antisera specific for CoREST and mSin3A.
Neuronal gene induction in Brm/BRG1-deficient cell lines
H Watanabe et al shown). shBrm/BRG1, which targets both Brm and BRG1 by binding to a nucleotide sequence that is common to these genes, successfully suppressed expression of both Brm and BRG1 (Figure 4a ). Expression of shBrm/BRG1 or shIni1 induced expression of synaptophysin and SCG10 mRNAs in NCI-H596 and HeLaS3 cells, whereas induction by shBrm or shBRG1 alone was much weaker (Figure 4b and data not shown). We also found that the elevation of synaptophysin mRNA is associated with increased production of synaptophysin protein in shBrm/BRG1-transduced NCI-H596 cells by Western blot (data not shown). In NCI-H1299 cells, which express endogenous Brm but not BRG1, expression of synaptophysin was significantly induced by shBrm vector transduction (data not shown). From these observations, we conclude that the SWI/SNF complex strongly represses expression of a subset of neuron-specific genes such as synaptophysin and SCG10 in non-neuronal epithelial cells. This result is consistent with a previous report that the SWI/SNF complex directly represses transcription in Saccharomyces cerevisiae (Martens and Winston, 2002) . Interestingly, repression by the SWI/SNF complex at the yeast SER3 gene is dependent primarily on one SWI/ SNF component, Snf2 (yeast homolog of Brm and BRG1). Since Ini1 is also required for the suppression of human neuronal genes in this study (Figure 4b ), we believe that detailed mechanisms would be different between these two cases. As for synapsin I expression, it was not induced at all by the expression of any of these shRNAs in either NCI-H596 or HeLaS3 cells (Figure 4b and data not shown), suggesting that there are some additional mechanisms of suppressing synapsin I transcription in these cell lines.
Since synaptophysin, SCG10 and synapsin I genes contain NRSF-binding sites (Mori et al., 1992; Schoch et al., 1996; Lietz et al., 2003) , we next examined whether the transcriptional suppression by the SWI/ SNF complex requires NRSF. When we introduced retrovirus vectors that expressed shRNAs targeting the NRSF gene (designated shNRSF) into NCI-H596 and NCI-H522 cells, transduction of shNRSF decreased expression of the NRSF mRNA by about one-fourth (Figure 4c ). In NCI-H596 cells, which are competent for the SWI/SNF complex, synaptophysin and SCG10 mRNAs were drastically induced, whereas the expression levels of these mRNAs were not significantly affected in NCI-H522 cells (Figure 4c ). Immunofluor- escent staining also showed that synaptophysin proteins were present in cytoplasm in shNRSF-and shBrm/ BRG1-transduced NCI-H596, but not shGFP-transduced cells (Figure 4d ). These results indicate that suppression of synaptophysin and SCG10 in non-neural cells requires both the functional SWI/SNF complex and NRSF. However, introduction of shNRSF, as is the case with shBrm/BRG1, did not induce expression of the synapsin I gene at all (Figure 4c) , further confirming that, in the synapsin I locus in certain cell lines, there are other suppression mechanisms that are independent of either NRSF or the SWI/SNF complex.
SWI/SNF complex interacts with a complex containing NRSF and its corepressors, mSin3A and CoREST To detect specific interactions between the SWI/SNF complex and NRSF in vivo, we constructed a series of Figure 4 Reduced expression of SWI/SNF subunits by shRNAs. (a) HeLaS3 cells were infected with shRNA-expressing retrovirus vectors targeted to two different regions of Brm (shBrm no. 1, 2), BRG1 (shBRG1), Ini1 (shIni1), a region common to both Brm and BRG1 (shBrm/ BRG1), and GFP (shGFP). Following puromycin selection, total cell lysates were prepared and analysed by Western blotting (10 mg protein/ each lane) with antisera specific for Brm, BRG1 and Ini1. shGFP vector-transduced cells were used as controls and gave essentially the same results as uninfected cells. (b) Total RNAs from parallel cultures of NCI-H596 cells prepared as in (a) were extracted, and levels of synaptophysin, SCG10, synapsin I, NRSF and GAPDH mRNAs were determined by semiquantitative RT-PCR. (c) NCI-H596 and NCI-H522 cells were infected with shRNA-expressing retrovirus targeted to NRSF (shNRSF) or shGFP. Total RNAs were prepared as in (b), and levels of synaptophysin, SCG10, synapsin I, NRSF and GAPDH mRNAs were determined by semiquantitative RT-PCR. (d) NCI-H596 cells were infected with shBrm/BRG1, shNRSF or shGFP retrovirus as in (a), and synaptophysin proteins were detected by fluorescent immunohistochemistry. IMR-32 was used as positive control for synaptophysin expression. Each DIC (differential interference contrast) image is also represented.
H Watanabe et al vectors expressing Flag-tagged full-length NRSF (F-NRSF), N-terminal half (N-NRSF) and C-terminal half (C-NRSF) (Figure 5a ). Immunofluorescent staining showed that, like BAF155 and CoREST, all the NRSF proteins were distributed exclusively in the nucleus (data not shown). At 3 days after the transfection of each construct into 293 cells, NRSF-containing complexes were immunoprecipitated with anti-Flag antibody, followed by Western blotting. As shown in Figure 5b , the immunoprecipitates of F-NRSF contained mSin3A and CoREST, both of which have been previously reported to interact with the N-terminus and C-terminus of NRSF, respectively (Andres et al., 1999; Huang et al., 1999; Naruse et al., 1999; Grimes et al., 2000; Roopra et al., 2000; Ballas et al., 2001) . Furthermore, Brm, BRG1 and BAF155 were all detected in the F-NRSF immunoprecipitates (Figure 5b ), indicating that the SWI/SNF complex is associated with an NRSF-containing large complex in vivo.
As for two NRSF truncation mutants, CoREST efficiently bound C-NRSF but not N-NRSF, whereas mSin3A bound N-NRSF but not C-NRSF (Figure 5b ), consistent with previous reports (Huang et al., 1999; Naruse et al., 1999; Roopra et al., 2000) . Furthermore, all the NRSF derivatives coimmunoprecipitated HDAC2 (Figure 5b ), which has been reported to bind tightly to two corepressors, mSin3 (Huang et al., 1999; Naruse et al., 1999) and CoREST (Ballas et al., 2001) . Importantly, Brm, BRG1 and BAF155 strongly associated with N-NRSF (Figure 5b ), indicating that NRSF interacts with the SWI/SNF complex principally through its N-terminal half domain that can bind mSin3A. We believe that the SWI/SNF complex is recruited to NRSF through mSin3A/B, because mSin3A/B corepressors have been reported to bind directly in vitro to such SWI/SNF subunits as Brm, BRG1 and BAF57 (Sif et al., 2001; Pal et al., 2003) . Interestingly, Battaglioli et al. (2002) reported that CoREST directly bound to BAF57 using yeast two-hybrid experiments. Whereas our results indicate that the C-NRSF/CoREST complex cannot associate with the SWI/SNF complex efficiently in vivo, we would like to speculate that the recruitment of the SWI/SNF complex would juxtapose BAF57 and CoREST to allow their direct interaction. Such a protein-protein interaction would reinforce the stability of a large complex containing NRSF, mSin3A, CoREST and the SWI/SNF complex ( Figure 5c ).
Synaptophysin is silenced through histone modification but not DNA methylation
To obtain greater insights into the molecular mechanisms performed by the association of the SWI/SNF and NRSF complexes, we analysed the status of histones Figure 3a , and harvested for chromatin immunoprecipitation (ChIP) analysis. After immunoprecipitation with various antisera, DNA in the renatured immunoprecipitates were amplified with two primer pairs that covered the NRSE region and the 3 0 -UTR region of the synaptophysin gene. We observed that both HDAC2 and CoREST were present around the NRSE independent of the status of Brm or BRG1, whereas these proteins were not detected around the 3 0 -UTR (Figure 6a ). These observations indicate that the NRSF/CoREST/HDAC complex is constitutively present in the NRSE independent of the SWI/SNF complex, which is consistent with previous reports that the NRSE is typically occupied by NRSF in non-neuronal cells (Huang et al., 1999; Battaglioli et al., 2002) . Exogenous BRG1 was present around the NRSE region but not the 3 0 -UTR (Figure 6a ). These findings suggest that a functional SWI/SNF complex is formed and recruited to the NRSF complex that would be initially present at NRSE. When Brm or BRG1 was expressed exogenously, the level of acetylated histone H4, but not acetylated histone H3, around the NRSE site of synaptophysin was significantly decreased, whereas no decrease in acetylated H4 was detected in the 3'-UTR region or in GAPDH locus (Figure 6a ). Therefore, we think recruitment of the SWI/SNF complex is associated with specific deacetylation of histone H4 in the nucleosomes around NRSE and possibly contributes to the suppression of synaptophysin expression. Since we also detected a subtle increase (about 1.3-fold) of synaptophysin and SCG10 mRNA levels in shNRSF-transduced NCI-H522 cells (Figure 4c ), we cannot exclude the possibility that the NRSF complex alone may retain a weak suppression activity. But we believe we can conclude that for the major suppression activity, NRSF and its corepressors should be associated with the functional SWI/SNF complex.
We next used an HDAC inhibitor FK228, which targets class I HDACs that include HDAC1 and HDAC2 (Furumai et al., 2002) , to examine whether histone H4 deacetylation is important for gene suppression in this system. In NCI-H596 and HeLaS3 cells, expression of the synaptophysin and SCG10 genes was drastically induced by 48 h treatment with FK228 (Figure 6b ), supporting the importance of histone acetylation for gene activation. Our observation that acetylation of histone H4 around NRSE is reduced specifically by exogenous expression of either Brm or BRG1 in NCI-H522 cells indicates that recruitment of the SWI/SNF complex would drastically enhance the catalytic activity of these HDACs. In contrast, expression of synapsin I mRNA was not inducible (Figure 6b) , again suggesting there are additional strong suppression mechanisms of this gene.
A subset of neuronal genes, such as NaChII, undergoes NRSF-mediated silencing through CpG methylation in rat fibroblast cells (Lunyak et al., 2002) . We have treated NCI-H596 with 5-azacytidine, but all the three neuronal genes were not induced (data not shown). Furthermore, no significant CpG methylation was observed in the CpG island present at synaptophysin locus in NCI-H596 when determined by bisulfite sequence method (Supplementary Figure 1) . Therefore, we think CpG methylation is not involved in the suppression of the synaptophysin gene in these cells, and believe that expression of the synaptophysin gene is largely dependent on the status of histone modification.
Lung cancer is the leading cause of cancer deaths in industrialized countries and is classified pathologically as SCLC or NSCLC (Linnoila and Aisner, 1995) . It was reported that approximately 10% of NSCLC patients showed a concomitant loss of Brm and BRG1 expression, leading to a poorer prognosis than that of patients with Brm/BRG1-positive tumors (Reisman et al., 2003; Figure 6 Studies of possible epigenetic effects at neuron-specific gene loci. (a) Chromatin immunoprecipitation (ChIP) analysis around the NRSE region of the synaptophysin gene. NCI-H522 cells were transfected with pCAGF1-IG (control), pCAGF1-IGBrm (Brm) and pCAGF1-IG-BRG1 (BRG1), and the DNAprotein complexes were subjected to immunoprecipitation with antisera against pan-acetyl H3 (a-acH3), pan-acetyl H4 (a-acH4), BRG1 (a-BRG1), HDAC2 (a-HDAC2), CoREST (a-CoREST) and control rabbit IgG (Control IgG). Immunoprecipitated DNAs were amplified with primers specific for the NRSE region and 3'-UTR of synaptophysin and the intron region of GAPDH. Aliquots of chromatin obtained before immunoprecipitation were also analysed (Input). (b) NCI-H596 and HeLaS3 cells were treated with increasing concentrations (0.3, 1, 3 nM) of FK228 for 48 h. Total RNAs were prepared, and semiquantitative RT-PCR of synaptophysin, SCG10, synapsin I and GAPDH was performed. nc indicates each cell line without FK228 treatment.
Neuronal gene induction in Brm/BRG1-deficient cell lines H Watanabe et al Fukuoka et al., 2004) . In the present study, we showed that loss of both Brm and BRG1 in NSCLC cell lines impairs the NRSF repression system, leading to increased expression of some neuron-specific genes, including synaptophysin. The induction of several NRSF target genes caused by the loss of both Brm and BRG1 will be useful to detect and target these tumors. Approximately 30% of lung carcinomas, including SCLC, have been reported to show NE characteristics, such as expression of NE markers (Carnaghi et al., 2001) . Intriguingly, we demonstrated here that the molecular mechanisms of neuronal gene expression in Brm/BRG1-deficient NSCLC cell lines are different from those observed in SCLC, which are caused by either expression of Mash1 or elimination of endogenous NRSF itself (Borges et al., 1997; Coulson et al., 2000; Gurrola-Diaz et al., 2003) . From the perspective of cancer etiology, it is noteworthy that both BRG1 and Brm show some tumor-suppressor activities (Wong et al., 2000; Yamamichi et al., 2005) and patients with Brm/BRG1-deficient lung carcinoma reveal poor prognosis (Reisman et al., 2003; Fukuoka et al., 2004) . We speculate that some target genes of NRSF would be involved in carcinogenesis in Brm/BRG1-deficient lung tumors. This idea is supported by the previous reports that loss of NRSF activity enhances their tumorigenicity in a subgroup of SCLC (Coulson et al., 2000; GurrolaDiaz et al., 2003) and also by a very recent observation that NRSF functions as a tumor suppressor in colorectal cancer (Westbrook et al., 2005) . In the future, ectopic expression of these NRSF target genes may be useful to identify Brm/BRG1-deficient lung tumors.
Materials and methods
Cell cultures NCI-H23, NCI-H522, NCI-H596, NCI-H1299, A427 and A549 (NSCLC), HeLaS3 (cervical adenocarcinoma), , PLAT (prepackaging cell line for retrovirus vector production; Morita et al., 2000) , 293 (human embryonic kidney) were maintained in high glucose Dulbecco's modified Eagle's medium (DMEM, Gibco/BRL) supplemented with 10% fetal bovine serum (FBS). FK228 (a gift from Fujisawa Corporation) was added to the culture medium at concentrations of 0.3-3 nM. Human embryonic kidney 293 cells and NCI-H522 cells were transfected with Lipofectamine Plus (Invitrogen) and Lipofectamine 2000 Reagent (Invitrogen), respectively. Plasmids A 4.8-kb EcoRI-NotI fragment of pSVhSNF2a (encoding fulllength human Brm; Chiba et al., 1994 ) and a 5.25-kb SalI-SpeI fragment of pSVhSNF2b (encoding full-length human BRG1; Chiba et al., 1994) were cloned into the multicloning site of pCAGF1-IG (Niwa et al., 1991) to generate pCAGF1-IG-Brm and pCAGF1-IG-BRG1, respectively. Directed mutagenesis PCR were performed using pCAGF1-IG-Brm and pCAGF1-IG-BRG1 to generate pCAGF1-IG-Brm (ATPmut) and pCAGF1-IG-BRG1 (KR), which have specific mutations of Brm and BRG1, respectively, to disrupt their ATPase activity (Khavari et al., 1993; Muchardt and Yaniv, 1993) . Oligonucleotides encoding the FLAG-tag were inserted into the multicloning site of pcDNA3.1 (Invitrogen) to generate pFlag-CMV vector. The EcoRI-XhoI fragment of pcDNA3-REST/NRSFmyc (Tabuchi et al., 2002) was subcloned into the EcoRI-XhoI sites of pFlag-CMV to generate pFlag-F-NRSF. Using pcDNA3-REST/NRSFmyc as template, PCR was performed with the following two primer sets; 5 0 -CCGAA TTCCCATGGATGTGCATACAGGAAGC-3 0 and 5 0 -TCTA GACTCGAGCTCCTGCC-3 0 , and 5 0 -GAATTCGGCTTAC AGTTATG-3 0 and 5 0 -GGCTCGAGTTATCAATGGCTGT CAACTTCCAGC-3 0 to obtain a 1.8-kb fragment encoding the C-terminal region of human NRSF (corresponding to amino acids 502-1097 of NRSF) and a 1.6-kb fragment encoding the N-terminal region of human NRSF (corresponding to amino acids 1-528 of NRSF), respectively. These fragments were subcloned into the EcoRI-XhoI site of pFlag-CMV to generate pFlag-C-NRSF and pFlag-N-NRSF, respectively. 
Isolation of membrane fraction
Cells were homogenized with a Dounce-homogenizer in HEPES buffer (25 mM HEPES (pH 7.4), 10 mM MgCl 2 , 0.25 M sucrose), and the postnuclear supernatants were centrifuged at 100 000 g at 41C. The pellets were lysed in Laemmli's loading buffer and used as the crude membrane fraction.
Co-immunoprecipitation and Western blotting
Immunoprecipitation assays were performed essentially as reported previously (Battaglioli et al., 2002) , with anti-FLAG M2 affinity gel (Sigma). Western blotting was performed as described previously (Mizutani et al., 2002) . Primary antibodies were rabbit anti-BRG1 polyclonal (Santa Cruz Biotech), rabbit anti-Brm polyclonal (Transgenic Inc.), rabbit anti-BAF155 polyclonal (Santa Cruz Biotech), mouse anti-Ini1 monoclonal (BD Transduction), rabbit anti-CoREST polyclonal (Upstate Biotech), rabbit anti-HDAC2 polyclonal (Santa Cruz Biotech), rabbit anti-mSin3A polyclonal (Upstate Biotech) and mouse anti-synaptophysin monoclonal (BD Transduction).
ChIP assay
ChIP assay was performed according to the manufacturer's protocol (Upstate Biotech). Specific antibodies for immunoprecipitation were rabbit anti-pan-acetylated H3 polyclonal (specific for residues 9 and 14, Upstate Biotechnology), rabbit anti-pan-acetylated H4 polyclonal (specific for residues 5, 8, 12 and 16, Upstate Biotech), anti-BRG1, anti-CoREST, anti-HDAC2 and normal rabbit IgG (Santa Cruz Biotech). After protein-DNA crosslinks in the immunoprecipitates were reversed, DNA was extracted for PCR. PCR primers were 5'-TGGGCTGTTCCAACGAGCGC-3 0 and 5 0 -AAGAGCGC ACTCCTTTTCTCC-3 0 for the NRSE region of synaptophysin, 5 0 -ATCTTGAGCAAGGCAAGAAGTGG-3 0 and 5 0 -TCTGTCCTCCTATTAACCTAGC-3 0 for the 3 0 -untranslated region (UTR) of synaptophysin, and 5 0 -AATGAATGG GCAGCCGTTAG-3 0 and 5 0 -AGCTAGCCTCGCTCCACC TGAC-3 0 for intron 2 of GAPDH.
Virus production and infection
Oligonucleotides 5 0 -CTAGCGGATCCATGAGAATTCG-3 0 and 5 0 -TCGACGAATTCTCATGGATCCG-3 0 were inserted into the NheI-SalI site of modified pQCXIH vector (Clontech) to generate BamHI and EcoRI restriction sites in the U3 region located in 3 0 -long terminal repeat (LTR). To generate pSSSP (pSIN-siRNA-SV40puro), CMV promoter-IRES-hygromycin of a pQCXIH-based plasmid was replaced by the SV40 promoter-puromycin fragment of pBabe-puro plasmid . pmU6 was constructed as reported previously (Yu et al., 2002) . To construct the pmU6-shRNA cassette, each of the following oligonucleotide pairs were annealed and inserted into the BbsI-EcoRI site of pmU6: shBrm/BRG1 corresponding to nt 1293-1311 of the Brm coding region and nt 1365-1383 of the BRG1 coding region, shBrm no. 1 corresponding to nt 2998-3018 of Brm coding region, shBrm no. 2 corresponding to nt 225-245 of Brm coding region, shIni1 corresponding to nt 834-854 of Ini1 coding region, shBRG1 corresponding to nt 1951-1970 of BRG1 coding region, and shNRSF corresponding to nt 511-531 of NRSF coding region. Oligonucleotide sequences are available upon request. BamHI-EcoRI fragments of each pmU6-shRNA cassette were subcloned into the BamHI-EcoRI site of pSSSP. Vesicular stomatitis virus G protein (VSV-G) pseudotype, murine leukemia virus-based retrovirus vectors were prepared with the PLAT prepackaging cell line (Morita et al., 2000) and transduced as described previously .
Immunocytochemistry NCI-H596 or IMR-32 cells were fixed in ice-cold acetone for 3 min. Cells were then incubated for 1 h in 5% goat serum and incubated with antisynaptophysin monoclonal antibody. Primary antibody binding was visualized with Alexa Fluor 488 conjugated anti-mouse IgG antibody (Molecular Probes Inc.,) for immunofluorescence detection. Cells were viewed using a Radience 2100 laser-scanning confocal microscope (BIO-RAD).
